StonvexLoading…
StonvexCore line items from KRO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.86B | $1.89B | $1.67B | $1.93B |
Operating Income | $-36.50M | $122.90M | $-56.00M | $159.60M |
Net Income | $-110.90M | $86.20M | $-49.10M | $104.50M |
EPS (Diluted) | $-0.96 | $0.75 | $-0.43 | $0.90 |
Total Assets | $1.82B | $1.91B | $1.84B | $1.93B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $33.20M | $106.70M | $194.70M | $327.80M |
Free Cash Flow OCF − CapEx | $-40.40M | $43.00M | $-41.90M | $18.50M |
Shares Outstanding | 115.00M | 115.00M | 115.00M | 115.10M |